
Sign up to save your podcasts
Or
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
4.9
1212 ratings
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
134 Listeners
41 Listeners
315 Listeners
106 Listeners
498 Listeners
689 Listeners
38 Listeners
279 Listeners
3,331 Listeners
17 Listeners
18 Listeners
13 Listeners
6 Listeners
90 Listeners
1,107 Listeners
29 Listeners
197 Listeners
517 Listeners
350 Listeners
426 Listeners
18 Listeners
368 Listeners
53 Listeners